查看所有供应商和价格请点击：
| 中文名 | 甲酸钙 |
|---|---|
| 英文名 | Calcium formate |
| 中文别名 | 蚁酸钙 |
| 英文别名 |
calcium formiate
Formic acid, calcium salt (2:1) Berylliumformate (6CI,7CI) Formic acid beryllium salt beryllium formiate formic acid,calcium formate Berylliumformiat Ameisensaeure,Berylliumformiat MFCD00036108 EINECS 208-863-7 Calciumformiat Ameisensaeure,Calciumformiat Calcium diformate Formic acid,berylliumsalt (8CI,9CI) Beryllium formate formic acid,beryllium formate |
| 密度 | 2,02 g/cm3 |
|---|---|
| 沸点 | 100.6ºC at 760mmHg |
| 熔点 | 300 °C |
| 分子式 | C2H2CaO4 |
| 分子量 | 130.113 |
| 闪点 | 29.9ºC |
| 精确质量 | 129.957901 |
| PSA | 52.60000 |
| LogP | 0.51920 |
| 外观性状 | 白色至近乎于白色细结晶粉末 |
| 储存条件 | 采用双层包装，防潮，按常规运输。 |
| 稳定性 | 按规格使用和贮存，不会发生分解，避免与氧化物接触。易溶于水，不溶于醇。0℃时100mL水中可溶解甲酸钙16.2g；100℃时，100mL水中可溶解甲酸钙18.4g。熔点高于300℃，强热发生分解，首先生成草酸钙，同时放出一氧化碳和氢气，最终产物为碳酸钙。 |
| 水溶解性 | SOLUBLE |
| 计算化学 | 1.疏水参数计算参考值（XlogP）:无 2.氢键供体数量:0 3.氢键受体数量:4 4.可旋转化学键数量:0 5.互变异构体数量:无 6.拓扑分子极性表面积80.3 7.重原子数量:7 8.表面电荷:0 9.复杂度:7.5 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:3 |
| 更多 | 1. 性状：白色结晶或结晶性粉末。略具似醋酸的气味。 2. 密度（g/ cm3,25/4℃）：2.02 3. 相对蒸汽密度（g/cm3,空气=1）：未确定 4. 熔点（ºC）：300 5. 沸点（ºC,常压）：未确定 6. 沸点（ºC,8kPa）：未确定 7. 折射率：1.376 8. 闪点（ºF）：8 9. 比旋光度（º）：未确定 10. 自燃点或引燃温度（ºC）：未确定 11. 蒸气压（kPa,25ºC）：未确定 12. 饱和蒸气压（kPa,55.1ºC）：未确定 13. 燃烧热（KJ/mol）：未确定 14. 临界温度（ºC）：未确定 15. 临界压力（KPa）：未确定 16. 油水（辛醇/水）分配系数的对数值：未确定 17. 爆炸上限（%,V/V）：未确定 18. 爆炸下限（%,V/V）：未确定 19. 溶解性：易溶于水 |
Synonym:Calcium diformate; Calcoform; Formic acid, calcium salt Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 36/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Irritating to eyes and skin. Potential Health Effects Eye: Causes moderate eye irritation. May cause chemical conjunctivitis. Skin: Causes skin irritation. Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Inhalation: Aspiration may lead to pulmonary edema. Causes irritation of the mucous membrane and upper respiratory tract. Chronic: Effects may be delayed. Section 4 - FIRST AID MEASURES Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. Skin: Get medical aid immediately. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Inhalation: Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: In case of fire, use carbon dioxide, dry chemical powder or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Storage: Store in a tightly closed container. Store in a cool, dry area away from incompatible substances. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 544-17-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Powder Color: clear colorless Odor: slight acetic acid odor pH: Not applicable. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: > 300 deg C Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Not available. Solubility in water: soluble in water Specific Gravity/Density: 2.02 Molecular Formula: C2H2CaO4 Molecular Weight: 130.11 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: None reported. Hazardous Decomposition Products: Carbon monoxide, carbon dioxide. Hazardous Polymerization: Will not occur. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 544-17-2: LQ5600000 LD50/LC50: CAS# 544-17-2: Draize test, rabbit, eye: 100 mg/24H Moderate; Oral, mouse: LD50 = 1920 mg/kg; Oral, rat: LD50 = 2650 mg/kg. Calcium formate @ 0.2 ppm for 2 years in rat drinking water did not affect growth, fertility, or function in up to 5 Carcinogenicity: Calcium formate - Not listed by ACGIH, IARC, or NTP. Other: See actual entry in RTECS for complete information. Section 12 - ECOLOGICAL INFORMATION Other No information available. Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XI Risk Phrases: R 36/38 Irritating to eyes and skin. Safety Phrases: S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 37/39 Wear suitable gloves and eye/face protection. WGK (Water Danger/Protection) CAS# 544-17-2: 1 Canada CAS# 544-17-2 is listed on Canada's DSL List. CAS# 544-17-2 is listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 544-17-2 is listed on the TSCA inventory. SECTION 16 - ADDITIONAL INFORMATION N/A |
|
毒理学数据: 1、皮肤/眼睛刺激数据：标准Draize测试兔子直接接触眼睛：100mg/24HREACTION SEVERITY：中度； 2、急性毒性：大鼠经口LD50：2650mg/kg，除致死剂量外无详细说明； 小鼠经口LD50：1920mg/kg，除致死剂量外无详细说明； 小鼠经静脉LD50：154mg/kg，除致死剂量外无详细说明； 生态学数据: 该物质对环境可能有危害，对水体应给予特别注意。
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| 符号 |
GHS05 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H318 |
| 警示性声明 | P280-P305 + P351 + P338 + P310 |
| 危害码 (欧洲) | Xi:Irritant |
| 风险声明 (欧洲) | R36/37/38 |
| 安全声明 (欧洲) | S26-S37/39 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 1 |
| RTECS号 | LQ5600000 |
| 海关编码 | 2915120000 |
| 上游产品 6 | |
|---|---|
| 下游产品 10 | |
| 海关编码 | 2915120000 |
|---|---|
| 中文概述 | 2915120000 甲酸盐。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:5.5%。普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2915120000 salts of formic acid。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |
